Astrana Health Inc reports results for the quarter ended June 30 - Earnings Summary

• Astrana Health Inc ASTH.OQ reported quarterly adjusted earnings of 19 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 40 cents. The mean expectation of ten analysts for the quarter was for earnings of 36 cents per share. Wall Street expected results to range from 31 cents to 49 cents per share.

• Revenue rose 34.7% to $654.81 million from a year ago; analysts expected $638.32 million.

• Astrana Health Inc's reported EPS for the quarter was 19 cents​.

• The company reported quarterly net income of $9.42 million.

• Astrana Health Inc shares had fallen by 12.3% this quarter and lost 30.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.4% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"

• Wall Street's median 12-month price target for Astrana Health Inc is $46.00, about 53.3% above its last closing price of $21.46

This summary was machine generated from LSEG data August 8 at 03:42 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)